Non-germline genetically engineered mouse models for translational cancer research

Joerg Heyer, Lawrence N. Kwong, Scott W. Lowe, Lynda Chin

Research output: Contribution to journalReview articlepeer-review

143 Scopus citations

Abstract

Genetically engineered mouse models (GEMMs) of cancer have affected virtually all areas of cancer research. However, the accelerated discovery of new cancer genes emerging from large-scale cancer genomics and new chemical entities pouring from the drug discovery pipeline have strained the capacity of traditional germline mouse models to provide crucial insights. This Review introduces new approaches to modelling cancer, with emphasis on a growing collection of non-germline GEMMs (nGEMMs). These offer flexibility, speed and uniformity at reduced costs, thus paving the way for much needed throughput and practical preclinical therapeutic testing models.

Original languageEnglish (US)
Pages (from-to)470-480
Number of pages11
JournalNature Reviews Cancer
Volume10
Issue number7
DOIs
StatePublished - Jul 2010

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Non-germline genetically engineered mouse models for translational cancer research'. Together they form a unique fingerprint.

Cite this